Abstract
Tacrolimus (or FK506) and cyclosporine are key standard immunosuppressive drugs that are widely used for prevention of rejection in kidney transplant patients. In Kenya, the number of kidney transplants continue to steadily rise and so is the use of these immunosuppressive drugs. However, little published data exists on therapeutic drug monitoring (TDM) for the two drugs among the kidney transplant patients in Kenya and Africa. We therefore set out to review information in our database pertaining to TDM tests done for tacrolimus and cyclosporine over a 10-year period with the aim of assessing the distribution of the drug levels in relation to the therapeutic ranges.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
